Brazil Clears Sanofi's $635M Medley Pharma Buy

By Leigh Kamping-Carder · May 20, 2010, 12:58 PM EDT

Brazil's antitrust enforcer has given its blessing to Sanofi-Aventis SA's €500 million ($635 million) acquisition of Medley Pharmaceuticals Ltd., provided the Brazilian drug company gives up rights to three of its...

To view the full article, register now.